申请人:Achillion Pharmaceuticals, Inc.
公开号:US20170066783A1
公开(公告)日:2017-03-09
Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R
12
or R
13
on the A group is an aryl, heteroaryl or heterocycle (R
32
) are provided. The inhibitors of Factor D described herein reduce the excessive activation of complement.